P53 The Early Lessons of COVID-19: The Need for a Broader Health-Economic Perspective

por Schöttler, M, Van der Schans, S, Postma, M, Boersma, C
Publicado 2022

PRS27 Incorporating Heterogeneity in Risk for Infection and Disease in Cost-Effectiveness of Preventative Strategies in Older Adults

por Zeevat, F., van der Schans, J., Boersma, C., Standaert, B., Postma, M.
Publicado 2020

P03: RATIONALE AND DEVELOPMENT OF AN E-HEALTH APPLICATION TO DELIVER PATIENT CENTERED CARE DURING TREATMENT FOR MULTIPLE MYELOMA IN THE NETHERLANDS.

por Geerts, P, Eijsink, J, Moser, A, ter Horst, P, Boersma, C, Postma, M
Publicado 2022

Prevotella intermedia infection causing acute and complicated aortitis—A case report

por Boersma, C., Kampschreur, L.M., Buter, H., Doorenbos, B.M., Klinkert, P., Koning, G.G.
Publicado 2017

P68 Investing in the Prevention of Infectious Disease Outbreaks: Fiscal Health Modelling for Assessing the Public Investment Case

por Schöttler, M, van der Schans, S, Connolly, M, Van der Schans, J, Boersma, C, Postma, M
Publicado 2022

Exploratory Analysis of the Economically Justifiable Price of a Hypothetical RSV Vaccine for Older Adults in the Netherlands and the United Kingdom

por Zeevat, F, Luttjeboer, J, Paulissen, J H J, van der Schans, J, Beutels, P, Boersma, C, Postma, M J
Publicado 2021

HTA51 Challenges and Opportunities of Health Technology Assessment in Older Adult Immunization

por van Dorst, P, Van der Schans, J, de Waure, C, Largeron, N, Roberts, C, Beck, E, Postma, MJ, Boersma, C
Publicado 2022